Serina Therapeutics, Inc.
Serina Therapeutics, Inc. (SER) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SER · as of Jun 9, 2026
Key Statistics
Explore Serina Therapeutics, Inc. Data
ser stock data · financialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
ser competitorsSER
ALGS
BRNS
CVM
GNTA
GRCEAbout Serina Therapeutics, Inc.
Serina Therapeutics, Inc. a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate inten…
what is serina therapeutics, inc. · ser stock overview · serina therapeutics, inc. company profile · who is serina therapeutics, inc. ceo · ser AMEX · serina therapeutics, inc. headquarters · serina therapeutics, inc. business segments
About Stock Overview & Key Data
Serina Therapeutics, Inc. (SER) is a Healthcare company in the Biotechnology industry, listed on AMEX since Jan 21, 2000. As of the latest trading session, SER stock price is $1.92, with a market capitalization of $20.8M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Serina Therapeutics, Inc. (SER) stock price is $1.92. The stock is traded on AMEX under the ticker symbol SER. The 52-week range is $1.22 – $7.92.